Literature DB >> 1002829

Serum dilution neutralization test for California group virus identification and serology.

H S Lindsey, C H Calisher, J H Mathews.   

Abstract

The serum dilution neutralization test was evaluated for serological diagnosis of California group arbovirus infections and identification of virus isolates. The technical advantages and the degree of subtype specificity of the serum dilution neutralization test over the hemagglutination inhibition test and the complement fixation test were demonstrated with paired specimens from human cases, single human survey sera, and sentinel rabbit sera. Twenty-one virus isolates from various geographical areas of the United States were also used to evaluate the efficacy of the serum dilution neutralization test for specific virus identification.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 1002829      PMCID： PMC274511          DOI： 10.1128/jcm.4.6.503-510.1976

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  9 in total

1.  ANTIBODIES IN MAN AGAINST TAHYNA AND LUMBO VIRUSES DETERMINED BY HEMAGGLUTINATION-INHIBITION AND TISSUE-CULTURE NEUTRALIZATION TESTS.

Authors:  C KUNZ; S M BUCKLEY; J CASALS
Journal:  Am J Trop Med Hyg       Date:  1964-09       Impact factor: 2.345

2.  ISOLATION OF CALIFORNIA ENCEPHALITIS GROUP VIRUS FROM A FATAL HUMAN ILLNESS.

Authors:  W H THOMPSON; B KALFAYAN; R O ANSLOW
Journal:  Am J Epidemiol       Date:  1965-03       Impact factor: 4.897

3.  Isolation of viruses from mosquitoes collected at Lumbo, Mozambique. I. Lumbo virus, a new virus isolated from Aedes (Skusea) pembaensis Theobald.

Authors:  R H KOKERNOT; B M McINTOSH; C B WORTH; M P WEINBREN
Journal:  Am J Trop Med Hyg       Date:  1962-09       Impact factor: 2.345

Review 4.  The growing importance of California arboviruses in the etiology of human disease.

Authors:  B E Henderson; P H Coleman
Journal:  Prog Med Virol       Date:  1971

5.  Antigenic patterns within the California-encephalitis-virus group.

Authors:  G E Sather; W M Hammon
Journal:  Am J Trop Med Hyg       Date:  1967-07       Impact factor: 2.345

6.  Preparation of La Crosse virus hemagglutinating antigen in BHK-21 suspension cell cultures.

Authors:  W A Chappell; P E Halonen; R F Toole; C H Calisher; L Chester
Journal:  Appl Microbiol       Date:  1969-09

7.  The preparation of arbovirus hemagglutinins by sonication and trypsin treatment.

Authors:  P Ardoin; D H Clarke; C Hannoun
Journal:  Am J Trop Med Hyg       Date:  1969-07       Impact factor: 2.345

8.  California encephalitis virus, a newly described agent.

Authors:  W M HAMMON; W C REEVES
Journal:  Calif Med       Date:  1952-11

9.  Evaluation of 4-(2-hydroxyethyl)-1-piperazineëthanesulfonic acid (HEPES) as a tissue culture buffer.

Authors:  C Shipman
Journal:  Proc Soc Exp Biol Med       Date:  1969-01
  9 in total
  97 in total

1.  Detection of anti-arboviral immunoglobulin G by using a monoclonal antibody-based capture enzyme-linked immunosorbent assay.

Authors:  A J Johnson; D A Martin; N Karabatsos; J T Roehrig
Journal:  J Clin Microbiol       Date:  2000-05       Impact factor: 5.948

2.  Evaluation of three commercially available Japanese encephalitis virus IgM enzyme-linked immunosorbent assays.

Authors:  Jaimie S Robinson; David Featherstone; Ravi Vasanthapuram; Brad J Biggerstaff; Anita Desai; Nalini Ramamurty; Anwarul Haque Chowdhury; Hardeep S Sandhu; Kathleen F Cavallaro; Barbara W Johnson
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

3.  Duplex microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies.

Authors:  Alison J Johnson; Amanda J Noga; Olga Kosoy; Robert S Lanciotti; Alicia A Johnson; Brad J Biggerstaff
Journal:  Clin Diagn Lab Immunol       Date:  2005-05

4.  Validation of a microsphere-based immunoassay for detection of anti-West Nile virus and anti-St. Louis encephalitis virus immunoglobulin m antibodies.

Authors:  Alison J Johnson; Ronald C Cheshier; Giorgio Cosentino; Heather P Masri; Valerie Mock; Rebecca Oesterle; Robert S Lanciotti; Denise A Martin; Amanda J Panella; Olga Kosoy; Brad J Biggerstaff
Journal:  Clin Vaccine Immunol       Date:  2007-07-03

5.  Indirect fluorescent-antibody technique for serological diagnosis of La Crosse (California) virus infections.

Authors:  B J Beaty; J Casals; K L Brown; C B Gundersen; D Nelson; J T McPherson; W H Thompson
Journal:  J Clin Microbiol       Date:  1982-03       Impact factor: 5.948

6.  Immunoglobulin M antibody capture enzyme-linked immunosorbent assay for diagnosis of St. Louis encephalitis.

Authors:  T P Monath; R R Nystrom; R E Bailey; C H Calisher; D J Muth
Journal:  J Clin Microbiol       Date:  1984-10       Impact factor: 5.948

7.  Detection of anti-West Nile virus immunoglobulin M in chicken serum by an enzyme-linked immunosorbent assay.

Authors:  Alison J Johnson; Stanley Langevin; Katherine L Wolff; Nicholas Komar
Journal:  J Clin Microbiol       Date:  2003-05       Impact factor: 5.948

8.  St. Louis encephalitis virus possibly transmitted through blood transfusion-Arizona, 2015.

Authors:  Heather Venkat; Laura Adams; Rebecca Sunenshine; Elisabeth Krow-Lucal; Craig Levy; Tammy Kafenbaum; Tammy Sylvester; Kirk Smith; John Townsend; Melissa Dosmann; Hany Kamel; Roberto Patron; Matthew Kuehnert; Pallavi Annambhotla; Sridhar V Basavaraju; Ingrid B Rabe
Journal:  Transfusion       Date:  2017-09-14       Impact factor: 3.157

9.  Chikungunya virus in US travelers returning from India, 2006.

Authors:  Robert S Lanciotti; Olga L Kosoy; Janeen J Laven; Amanda J Panella; Jason O Velez; Amy J Lambert; Grant L Campbell
Journal:  Emerg Infect Dis       Date:  2007-05       Impact factor: 6.883

10.  Experimental passage of St. Louis encephalitis virus in vivo in mosquitoes and chickens reveals evolutionarily significant virus characteristics.

Authors:  Alexander T Ciota; Yongqing Jia; Anne F Payne; Greta Jerzak; Lauren J Davis; David S Young; Dylan Ehrbar; Laura D Kramer
Journal:  PLoS One       Date:  2009-11-17       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.